Calculation of your study is finished. Please find your results below.

A study for a 62 year old woman who takes Pred Mild, Bupropion Hydrobromide, Atorvastatin Calcium (an AI-powered real world drug study)

Summary:

2,162 females aged 62 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 62 year old female patient who has Infection, Anxiety, High Cholesterol. The study is created by eHealthMe based on reports from sources including the FDA.


On Sep, 30, 2025

2,162 females aged 62 (±5) who take Pred Mild, Bupropion Hydrobromide, Atorvastatin Calcium and have adverse effects are studied.


Number of reports submitted per year:

Pred Mild, Bupropion Hydrobromide, Atorvastatin Calcium for a 62-year old woman.

Information of the patient in this study:

  • Age: 62
  • Gender: female
  • Conditions: Infection, Anxiety, High Cholesterol
  • Drugs taken:
    • Pred Mild (prednisolone acetate)
    • Bupropion Hydrobromide (bupropion hydrobromide)
    • Atorvastatin Calcium (atorvastatin calcium)

Common drug interactions *:

  1. Fatigue (feeling of tiredness): 213 people, 9.85%
  2. Fall : 187 people, 8.65%
  3. Nausea (feeling of having an urge to vomit): 185 people, 8.56%
  4. Chronic Kidney Disease : 170 people, 7.86%
  5. Diarrhea : 149 people, 6.89%
  6. Pain : 143 people, 6.61%
  7. Headache (pain in head): 134 people, 6.20%
  8. Acute Kidney Failure : 133 people, 6.15%
  9. Nausea And Vomiting : 123 people, 5.69%
  10. Dyspnea (difficult or laboured breathing): 123 people, 5.69%
  11. Pneumonia : 119 people, 5.50%
  12. Dizziness : 116 people, 5.37%
  13. Weakness : 115 people, 5.32%
  14. Drug Ineffective : 105 people, 4.86%
  15. Joint Pain : 98 people, 4.53%
  16. Malaise (a feeling of general discomfort or uneasiness): 97 people, 4.49%
  17. Weight Decreased : 95 people, 4.39%
  18. Back Pain : 91 people, 4.21%
  19. Sinusitis (inflammation of sinus): 84 people, 3.89%
  20. Hair Loss : 83 people, 3.84%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 278 people, 12.86%
  2. Pain : 254 people, 11.75%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 151 people, 6.98%
  4. Diabetes : 146 people, 6.75%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 139 people, 6.43%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 101 people, 4.67%
  7. Insomnia (sleeplessness): 97 people, 4.49%
  8. Asthma : 91 people, 4.21%
  9. Constipation : 86 people, 3.98%
  10. Type 2 Diabetes : 76 people, 3.52%
  11. Indigestion : 76 people, 3.52%
  12. Hypersensitivity : 63 people, 2.91%
  13. Fibromyalgia (a long-term condition which causes pain all over the body): 61 people, 2.82%
  14. Sleep Disorder : 58 people, 2.68%
  15. Cardiac Disorder : 56 people, 2.59%
  16. Nausea (feeling of having an urge to vomit): 55 people, 2.54%
  17. Psoriasis (immune-mediated disease that affects the skin): 55 people, 2.54%
  18. Arthritis (form of joint disorder that involves inflammation of one or more joints): 54 people, 2.50%
  19. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 53 people, 2.45%
  20. Osteoporosis (bones weak and more likely to break): 53 people, 2.45%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Aspirin (276 people, 12.77%)
  2. Nexium (261 people, 12.07%)
  3. Vitamin D3 (255 people, 11.79%)
  4. Metformin (244 people, 11.29%)
  5. Synthroid (220 people, 10.18%)
  6. Prilosec (203 people, 9.39%)
  7. Amlodipine (184 people, 8.51%)
  8. Gabapentin (170 people, 7.86%)
  9. Protonix (169 people, 7.82%)
  10. Tylenol (162 people, 7.49%)
  11. Pantoprazole (161 people, 7.45%)
  12. Lyrica (159 people, 7.35%)
  13. Cymbalta (157 people, 7.26%)
  14. Vitamin D (156 people, 7.22%)
  15. Calcium (147 people, 6.80%)
  16. Prevacid (142 people, 6.57%)
  17. Vitamin B12 (133 people, 6.15%)
  18. Lexapro (133 people, 6.15%)
  19. Lasix (130 people, 6.01%)
  20. Ondansetron (129 people, 5.97%)

Drug effectiveness *:

Pred Mild:

n/a

Bupropion Hydrobromide:
  • not at all: 0 %
  • somewhat: 14.29 %
  • moderate: 42.86 %
  • high: 28.57 %
  • very high: 14.29 %
Atorvastatin Calcium:
  • not at all: 0 %
  • somewhat: 14.29 %
  • moderate: 28.57 %
  • high: 42.86 %
  • very high: 14.29 %

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug interactions:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.